RedHill Biopharma Reports 2016 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
RedHill Biopharma (RDHL) Tops Q1 Loss Views
July 26, 2016 7:08 AM EDTRedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.06), $0.52 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
... More